Pharmacogenomic characterization of gemcitabine response – a framework for data integration to enable personalized medicine
HLA alleles and hypersensitivity to carbamazepine
Strongly increased exposure of meloxicam in CYP2C9*3/*3 individuals
Novel CYP2A6 variants identified in African Americans are associated with slow nicotine metabolism in vitro and in vivo
A pharmacogenetic study of aldehyde oxidase I in patients treated with XK469
PharmGKB summary